Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1)

Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1)

US Patent 6057131 · Granted May 2, 2000

Estimated economic value: $11,371,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acids encoding anti-TREM-1 antibodies2024
Anti-TREM-1 antibodies and uses thereof2024
Chimeric antigen receptors targeting TIM-12023
Fast-off rate serum albumin binding fibronectin type III domains2022
Serum albumin-binding fibronectin type III domains2021
Antibodies that bind human CD27 and uses thereof2021
Anti-TREM-1 antibodies and uses thereof2021
Serum albumin binding molecules2021
Fast-off rate serum albumin binding fibronectin type III domains2020
Serum albumin-binding fibronectin type III domains2019
Serum albumin binding molecules2019
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2017